Intrathecal anti-tetanus human immunoglobulin in the treatment of neonatal tetanus

Journal of the College of Physicians and Surgeons Pakistan

Volumn 21, Issue 9, 2011, Pages 539-541

  Ahmad, Ameer ^a   Qaisar, Imran ^a   Naeem, Mohammad ^a   Mazhar, Atta Ullah ^a   Ashfaq, Mohammad ^b  

^a QUAID E AZAM MEDICAL COLLEGE   (Pakistan)

^b NATIONAL INSTITUTE OF CHILD HEALTH   (Pakistan)

Author keywords

Intrathecal immunoglobulin; Neonate; Tetanus

Indexed keywords

TETANUS ANTIBODY;

ABSENCE OF SIDE EFFECTS; ARTICLE; ASSISTED VENTILATION; CONTROLLED STUDY; DRUG EFFICACY; FEVER; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN APNEA; NEWBORN TETANUS; REFRACTORY PERIOD;

ANTIDOTES; CHI-SQUARE DISTRIBUTION; DEVELOPING COUNTRIES; HUMANS; IMMUNOGLOBULINS; IMMUNOLOGIC FACTORS; INFANT, NEWBORN; INJECTIONS, SPINAL; LENGTH OF STAY; PAKISTAN; TETANUS; TETANUS ANTITOXIN;

EID: 80052699987     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ijaz I, Khan IH. Risk factors of neonatal tetanus. Pak Paed J 2000; 24:69-72.
2. World Health Organization. Expanded programme on immunization: progress and evaluation reported by the Director General. Presented at the 39th World Health Assembly; 1986.
3. World Health Organization. Immunization surveillance, assessment and monitoring: Pakistan reported cases [Internet]. 2010. Available from: http://www.who.int/immunizationmonitoring/en/ globalsummarytimeseries/tsinci dencbycountry.cfm?=PAK
4. Ali M, Mazhar A, Irshad ul Haq M. Tetanus neonatorum. Pak Paed J 2002; 26:187-90.
5. Butt TK, Shazia M, Ali L, Hamid H. Neonatal seizures - etiology, treatment and outcome. Pak Paed J 2005; 29:151-6.
6. Junejo AA, Abbasi KA, Bouk GR. Profile of tetanus in children at Children Hospital Chandka Medical College, Larkana. Med Channel 2010; 16:211.
7. Arnon SS. Tetanus (clostridium tetani). In: Behrman RE, Kleigman RM, Jenson HB, editors. Nelson text book of pediatrics. 18th ed. Philadelphia: W.B. Saunders; 2007. p. 951-3.
8. Patel J C, Joag G G. Grading of tetanus to evaluate prognosis. Indian J Med Sci 1959; 13:834-40.
9. Sanders RK, Martyn B, Joseph R, Peacock ML. Intrathecal antitetanus serum (Horse) in the treatment of tetanus. Lancet 1977; 309:974-7.
10. Geeta MG, Krishna KP, Mathews L. Intrathecal tetanus immunoglobulin in the management of tetanus. Indian J Pediatr 2007; 74:43-5.
11. Thwaites CL. Preventing and treating tetanus: the challenge continues in the face of neglect and lack of research. BMJ 2003; 326:117-8.
12. Kabura L, Ilibagiza D, Menten J, Van den Ende J. Intrathecal vs. intramuscular administration of human antitetanus immunoglobulin or equine tetanus antitoxin in the treatment of tetanus: a meta-analysis. Trop Med Int Health 2006; 11:1075- 81.
13. Abrutyn E, Berlin JA. Intrathecal therapy in tetanus, ametaanalysis. JAMA 1991; 266:2262-7.
14. Menon J, Mathews L. Intrathecal immunoglobulin in the treatment of tetanus. Indian Pediatr 2002; 39:654-7.
15. Miranda-Filho Dde B, Ximenes RA, Barone AA, Vaz VL, Vieira AG, Albuquerque VM. Randomized controlled trial of tetanus treatment with antitetanus immunoglobulin by the intrathecal or intramuscular route. BMJ 2004; 328:615. Epub 2004 May 5.
16. Neequaye J, Nkrumah FK. Failure of intrathecal antitetanus serum to improve survival in neonatal tetanus. Arch Dis Child 1983; 58:276-8.
17. Chugh K, Sehgal H. Evaluation of intrathecal human immunoglobulin in neonatal tetanus. Indian Pediatr 1985; 22:153-8.
18. Singh AK, Bansal A, Geol SP, Agarwal VK. Intrathecal antitetanus serum (horse) with steroid in the treatment of neonatal tetanus. Arch Dis Child 1980; 55:527-31.